Case Report

The Journal of the Korean Rheumatism Association 2007; 14(3): 291-296

Published online September 30, 2007

© Korean College of Rheumatology

전신홍반루푸스에서 Cyclosporine 투여 중 발생한 Reversible Posterior Leukoencephalopathy Syndrome 1예

신재대ㆍ손자영ㆍ김대영ㆍ박진홍ㆍ김건우ㆍ송은주*김지민*ㆍ김경훈*ㆍ남언정*ㆍ강영모*

대구 파티마병원 내과, 경북대학교 의과대학 내과학교실*

Reversible Posterior Leukoencephalopathy Syndrome in a Patient withSystemic Lupus Erythematosus Treated with Cyclosporine

Jae Dae Shin, M.D., Ja Young Son, M.D., Dae Young Kim, M.D., Jin Hong Park, M.D., Gun Woo Kim, M.D., Eun Joo Song, M.D.*, Ji Min Kim, M.D.*, Kyung Hoon Kim, M.D.*, Eon Jeong Na

Department of Internal Medicine, Daegu Fatima Hospital, Kyungpook National University School of Medicine*, Daegu, Korea

Correspondence to : Gun Woo Kim

Abstract

Reversible posterior leukoencephalopathy syndrome (RPLS) is characterized clinically by headache, seizure, altered mental status and visual impairment. Neuroimaging shows reversible white matter edema predominantly in the parietal and occipital lobes. RPLS has been associated with a variety of conditions, including hypertensive encephalopathy, renal failure, immunosupressive therapy, and autoimmune diseases such as systemic lupus erythematosus (SLE). We report a young woman of SLE presented with headache, generalized tonic-clonic seizure and altered mental status, after taking azathioprine and cyclosporine. The brain magnetic resonance images showed bilateral hyperintensitiy in the posterior parietal, occipital, temporal lobes and cerebellum on T2-weighted images and fluid attenuated inversion recovery images, whereas diffusion-weighted images showed isointensity in the same distribution. The patient was improved clinically and radiologically one week after the control of hypertension and discontinuation of cyclosporine.

Keywords Reversible posterior leukoencephalopathy syndrome, Systemic lupus erythematosus, Cyclosporine

Article

Case Report

The Journal of the Korean Rheumatism Association 2007; 14(3): 291-296

Published online September 30, 2007

Copyright © Korean College of Rheumatology.

전신홍반루푸스에서 Cyclosporine 투여 중 발생한 Reversible Posterior Leukoencephalopathy Syndrome 1예

신재대ㆍ손자영ㆍ김대영ㆍ박진홍ㆍ김건우ㆍ송은주*김지민*ㆍ김경훈*ㆍ남언정*ㆍ강영모*

대구 파티마병원 내과, 경북대학교 의과대학 내과학교실*

Reversible Posterior Leukoencephalopathy Syndrome in a Patient withSystemic Lupus Erythematosus Treated with Cyclosporine

Jae Dae Shin, M.D., Ja Young Son, M.D., Dae Young Kim, M.D., Jin Hong Park, M.D., Gun Woo Kim, M.D., Eun Joo Song, M.D.*, Ji Min Kim, M.D.*, Kyung Hoon Kim, M.D.*, Eon Jeong Na

Department of Internal Medicine, Daegu Fatima Hospital, Kyungpook National University School of Medicine*, Daegu, Korea

Correspondence to:Gun Woo Kim

Abstract

Reversible posterior leukoencephalopathy syndrome (RPLS) is characterized clinically by headache, seizure, altered mental status and visual impairment. Neuroimaging shows reversible white matter edema predominantly in the parietal and occipital lobes. RPLS has been associated with a variety of conditions, including hypertensive encephalopathy, renal failure, immunosupressive therapy, and autoimmune diseases such as systemic lupus erythematosus (SLE). We report a young woman of SLE presented with headache, generalized tonic-clonic seizure and altered mental status, after taking azathioprine and cyclosporine. The brain magnetic resonance images showed bilateral hyperintensitiy in the posterior parietal, occipital, temporal lobes and cerebellum on T2-weighted images and fluid attenuated inversion recovery images, whereas diffusion-weighted images showed isointensity in the same distribution. The patient was improved clinically and radiologically one week after the control of hypertension and discontinuation of cyclosporine.

Keywords: Reversible posterior leukoencephalopathy syndrome, Systemic lupus erythematosus, Cyclosporine

JRD
Jan 01, 2025 Vol.32 No.1, pp. 1~7
COVER PICTURE
Cumulative growth of rheumatology members and specialists (1980~2024). Cumulative distribution of the number of the (A) Korean College of Rheumatology members and (B) rheumatology specialists. (J Rheum Dis 2025;32:63-65)

Stats or Metrics

Share this article on

  • line

Related articles in JRD

Journal of Rheumatic Diseases

pISSN 2093-940X
eISSN 2233-4718
qr-code Download